Thallous Chloride T1-201
- Generic Name
- Thallous Chloride T1-201
Comparison of Diagnostic Rest/Stress SPECT Results for Patients With Myocardial Ischemia and Infarction Using Myoview in Both Single and Dual Isotope Acquisition Approaches
Phase 4
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Drug: Technetium Tc99m Tetrofosmin injections
- First Posted Date
- 2006-09-27
- Last Posted Date
- 2007-12-05
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 291
- Registration Number
- NCT00381316
- Locations
- 🇺🇸
GE Healthcare, Princeton, New Jersey, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath